Restech is a United States based startup that specializes in providing minimally invasive tools and therapies for accurately diagnosing, managing, and treating reflux. Founded in 2003, Restech’s mission is to offer solutions related to the complexity of gastric-related diseases. The company's tools are designed to assist multiple specialties in improving the standard of care for patients with reflux and fecal incontinence, ultimately leading to a transformation in the algorithm of care for tens of millions of patients. Restech's innovative approach is disrupting the way physicians gather necessary data, enabling them to make more informed decisions in patient care. While the exact details of their last investment and the involved investors are not currently available, Restech's commitment to revolutionizing the medical devices and biotechnology industries remains evident through their cutting-edge solutions. With its focus on minimally invasive technologies and dedication to improving patient outcomes, Restech stands poised to continue making significant strides in the field of healthcare.
There is no investment information
No recent news or press coverage available for Restech.